Search results
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science.
Studies include:…
View more
Author(s):
Derek P Chew
,
Harvey D White
Added:
3 years ago
The cumulative evidence base informing almost every aspect of myocardial infarction acute coronary syndrome (ACS) care is expansive and has been associated with a decline in the rate of mortality. Within the context of current-era clinical trials of ST-segment-elevation myocardial infarction, 30-day mortality rates of 4–5% have now been reported for high-risk individuals,1,2 with similar rates…
View more
Robert P Giugliano
Research Area(s) / Expertise:
Job title: Associate Professor
Author
Vivek Reddy
Job title: Director of Cardiac Arrhythmia Services
Author
Author(s):
Dante J Graves
,
Rick W Meece
Added:
3 years ago
Despite significant improvements for earlier detection of and medical therapies for heart failure, a recent American Heart Association (AHA) study stated that the actual incidence of heart failure has not declined. Of interest is the fact that the AHA found hypertension precedes development of heart failure in 91% of cases. The increasing prevalence of these combined disease states escalates the…
View more
Author(s):
Samuel S Engel
Added:
6 months ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients with nonalcoholic fatty liver disease and type 2 diabetes (NCT04944992).The phase IIa study randomized 145 participants (efinopegdutide, n = 72; semaglutide, n = 73). The majority (55.2%) of participants…
View more
Author(s):
Harriette Van Spall
,
Neha Pagidipati
,
Christopher B Granger
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University,CA) is joined by Dr Neha J Pagidipati (Duke University Medical Center, US)and Dr Christopher B Granger (Duke University Medical Center, US)to discuss the results of the COORDINATE-Diabetes trial (NCT03936660).The COORDINATE-Diabetes trial is testing a multifaceted intervention to improve the care of people with type 2…
View more
Frits Prinzen
Job title: Professor of Physiology
Author
Cardiovascular Research Foundation
Supplier
Houssam Younes
Research Area(s) / Expertise:
Job title: Chairman, Department of Vascular Surgery, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi
Author